Table 2.

Symptom indices, perceived stress, HRQoL, stress resilience, mental health, and sleep quality outcomes.

	Control group (n = 52)		Intervention group (n = 49)		p Value
	Baseline	End of study	Baseline	End of study	Between-group end of study
PSS	18.4 ± 6.0	18.2 ± 7.3	18.1 ± 5.8	14.3 ± 5.9	<0.001
pMayo	1.7 ± 1.8	1.3 ± 1.7	1.0 ± 1.3	0.8 ± 1.1	0.42
HBI	4.4 ± 2.7	4.5 ± 2.8	4.1 ± 2.3	4.2 ± 3.7	0.96
HADS total	14.1 ± 4.8	14.6 ± 5.4	14.1 ± 4.9	10.9 ± 4.2	<0.001
HADS anxiety	8.69 ± 3.25	8.96 ± 3.63	9.00 ± 3.39	7.00 ± 2.92	<0.001
HADS depression	5.20 ± 2.85	5.17 ± 3.10	4.98 ± 2.57	3.66 ± 2.18	0.002
Belief that stress impacts IBD	73.3 ± 22.7	72.0 ± 26.9	73.8 ± 14.3	68.7 ± 25.3	0.68
Global PSQI	8.2 ± 3.7	7.9 ± 3.6	8.6 ± 3.1	7.4 ± 3.5	0.187
SIBDQ	48.1 ± 8.8	50.2 ± 9.7	48.2 ± 8.9	55.2 ± 7.2	<0.001
EQ-5D visual analog scale	68.2 ± 18.5	70.4 ± 17.1	67.6 ± 15.0	77.2 ± 11.9	0.003
CD-RISC	67.7 ± 13.6	68.1 ± 14.8	64.5 ± 12.7	71.5 ± 12.8	<0.001
PWB self-acceptance	17.0 ± 3.5	17.3 ± 3.3	15.2 ± 3.5	16.7 ± 3.4	0.23
PWB purpose	17.0 ± 3.3	16.8 ± 3.5	15.6 ± 3.2	16.5 ± 3.3	0.31
PWB environmental mastery	14.9 ± 3.5	15.5 ± 3.5	14.2 ± 3.2	15.7 ± 3.5	0.24
PWB positive relations	16.4 ± 4.1	16.5 ± 4.0	15.8 ± 3.7	17.3 ± 3.6	0.008
PWB autonomy	15.8 ± 3.9	15.8 ± 3.8	15.1 ± 3.6	16.3 ± 3.0	0.082
PWB growth	18.3 ± 2.7	18.2 ± 3.2	17.3 ± 2.6	18.4 ± 2.6	0.124

CD-RISC, Connor–Davidson Resilience Scale; EQ-5D, EuroQol-5 Dimensions; HADS, Hospital Anxiety and Depression Scale; HBI, Harvey-Bradshaw Index; HRQoL, health-related quality of life; IBD, inflammatory bowel disease; pMayo, partial Mayo score; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; PWB, Psychological Well-being Scale; SIBDQ, Short Inflammatory Bowel Disease Questionnaire. The italicized p-values are statistically significant.